Symbol="IBRX"
AssetType="Common Stock"
Name="Immunitybio Inc"
Description="ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy. "
CIK="1326110"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="3530 JOHN HOPKINS COURT, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="750526000"
EBITDA="-352710016"
PERatio="None"
PEGRatio="None"
BookValue="-1.457"
DividendPerShare="0"
DividendYield="0"
EPS="-1.11"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-628.04"
ReturnOnAssetsTTM="-0.763"
ReturnOnEquityTTM="0"
RevenueTTM="592000"
GrossProfitTTM="240000"
DilutedEPSTTM="-1.11"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.171"
AnalystTargetPrice="4.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4822.33"
PriceToBookRatio="-"
EVToRevenue="5498.73"
EVToEBITDA="-8.89"
Beta="-0.311"
num_52WeekHigh="7.8"
num_52WeekLow="1.21"
num_50DayMovingAverage="2.49"
num_200DayMovingAverage="3.418"
SharesOutstanding="456247000"
DividendDate="None"
ExDividendDate="None"
symbol="IBRX"
open="1.84"
high="1.84"
low="1.62"
price="1.65"
volume="3170033.00"
latest_trading_day="2023-08-21"
previous_close="1.81"
change="-0.17"
change_percent="-9.1160%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="50"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="4107792"
Change_recent_avg="0.02"
Delta_recent_avg="0.31"
Variance_recent_avg="0.16"
Change_ratio_recent_avg="-0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="111"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_negative_thumbnail_id_2="1093"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0126.jpeg"
image_neutral_thumbnail_id_1="549"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_neutral_thumbnail_id_2="556"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_positive_thumbnail_id_1="686"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0022.jpeg"
image_positive_thumbnail_id_2="953"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0115.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
